NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Chai Discovery

Chai Discovery

Private
San Francisco, CaliforniaAI, Data & Cloud Infrastructurehttps://www.chaidiscovery.com/

Last Round

Series C

Jul 14, 2026

Est. Valuation

$3.8B

Total Funding Raised

$630M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Chai Discovery is a biotechnology company that offers a generative AI platform for designing and reprogramming biochemical molecules to accelerate drug discovery.

Sector

AI, Data & Cloud Infrastructure

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Revenue Share, Services & Consulting

AI Layer

Foundation

Keywords

AI drug discoveryfoundation modelde novo antibody designbiology foundation modelmolecular designgenerative biologygenerative antibody designbiologics discoverymolecular structure predictionin silico drug designcomputational drug designmolecular engineeringAI for pharmafrontier AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chai Discovery Comps

Public and private peers based on sector, stage, and business model.

Chai Discovery comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Chai Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 14, 2026
Series BDec 15, 2025
Series AAug 6, 2025
SeedSep 9, 2024

Chai Discovery Investors

Notable investors and investment history

Chai Discovery investors
InvestorRounds
Bain Capital VenturesSeries C
DST GlobalSeries A
NeoSeries B, Seed, Series A
SV AngelSeries B, Series A
AvraSeries C
Oak HC/FTSeries C, Series B
DimensionSeries B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 22, 2026

    Grew 21% QoQ, from 29 to 35 employees.

  • Jan 17, 2026

    Developing Chai-2 algorithm to create antibodies for fighting illnesses.

Chai Discovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chai Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chai Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range36
Year Founded2023
Last FundingJul 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.